Tenaya Therapeutics IncNASDAQ:TNYA
- LAST PRICE1.9700
- TODAY'S CHANGE (%)-0.0050 (-0.2532%)
- Bid / Lots1.9700/ 1
- Ask / Lots2.0300/ 5
- Open / Previous Close2.0000 / 1.9750
- Day Range
- 52 Week Range
- Volume218,319
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TNYA |
|---|---|---|
| 09:32 ET | 5092 | 1.98 |
| 09:34 ET | 5740 | 1.92 |
| 09:36 ET | 6480 | 1.91 |
| 09:38 ET | 1100 | 1.96 |
| 09:41 ET | 900 | 1.955 |
| 09:45 ET | 1400 | 1.96 |
| 09:48 ET | 100 | 1.965 |
| 09:50 ET | 300 | 1.98 |
| 09:52 ET | 500 | 2 |
| 09:57 ET | 338 | 2 |
| 10:01 ET | 200 | 1.98 |
| 10:03 ET | 500 | 1.98 |
| 10:06 ET | 100 | 1.98 |
| 10:08 ET | 100 | 1.985 |
| 10:10 ET | 1605 | 2 |
| 10:12 ET | 100 | 1.99 |
| 10:14 ET | 100 | 1.98 |
| 10:17 ET | 5297 | 1.985 |
| 10:19 ET | 1580 | 1.98 |
| 10:21 ET | 5000 | 1.98 |
| 10:26 ET | 13009 | 1.96 |
| 10:30 ET | 100 | 1.965 |
| 10:32 ET | 3443 | 1.975 |
| 10:33 ET | 132 | 1.976 |
| 10:35 ET | 2800 | 1.975 |
| 10:39 ET | 3200 | 1.975 |
| 10:42 ET | 5100 | 1.99 |
| 10:44 ET | 3200 | 1.98 |
| 10:46 ET | 500 | 1.98 |
| 10:51 ET | 300 | 1.97 |
| 10:53 ET | 100 | 1.99 |
| 10:55 ET | 500 | 1.99 |
| 10:57 ET | 200 | 1.9983 |
| 11:00 ET | 2167 | 2 |
| 11:02 ET | 700 | 1.99 |
| 11:04 ET | 100 | 1.98 |
| 11:08 ET | 526 | 1.99 |
| 11:11 ET | 1300 | 2 |
| 11:13 ET | 100 | 1.98 |
| 11:20 ET | 100 | 2 |
| 11:22 ET | 200 | 2 |
| 11:24 ET | 100 | 2 |
| 11:26 ET | 100 | 2 |
| 11:29 ET | 200 | 1.98 |
| 11:33 ET | 100 | 2 |
| 11:36 ET | 4945 | 2 |
| 11:38 ET | 100 | 1.99 |
| 11:40 ET | 320 | 2 |
| 11:47 ET | 200 | 1.99 |
| 11:49 ET | 200 | 2.01 |
| 11:51 ET | 324 | 2.01 |
| 11:54 ET | 300 | 2 |
| 11:56 ET | 100 | 2 |
| 11:58 ET | 100 | 1.99 |
| 12:05 ET | 1102 | 1.98 |
| 12:12 ET | 100 | 2 |
| 12:14 ET | 200 | 1.98 |
| 12:18 ET | 1000 | 1.98 |
| 12:25 ET | 300 | 1.968 |
| 12:27 ET | 100 | 1.96 |
| 12:38 ET | 438 | 1.96 |
| 12:43 ET | 500 | 1.96 |
| 12:45 ET | 100 | 1.98 |
| 12:48 ET | 100 | 1.96 |
| 12:50 ET | 100 | 1.98 |
| 12:52 ET | 150 | 1.978 |
| 12:54 ET | 282 | 1.9783 |
| 12:56 ET | 250 | 1.97 |
| 12:59 ET | 1822 | 1.9437 |
| 01:03 ET | 150 | 1.9647 |
| 01:06 ET | 100 | 1.96 |
| 01:10 ET | 100 | 1.94 |
| 01:12 ET | 564 | 1.9699 |
| 01:19 ET | 100 | 1.94 |
| 01:21 ET | 100 | 1.94 |
| 01:26 ET | 4937 | 1.955 |
| 01:30 ET | 400 | 1.954 |
| 01:32 ET | 3500 | 1.95 |
| 01:33 ET | 300 | 1.95 |
| 01:37 ET | 400 | 1.96 |
| 01:42 ET | 100 | 1.97 |
| 01:46 ET | 100 | 1.965 |
| 01:50 ET | 1830 | 1.97 |
| 02:06 ET | 1600 | 1.98 |
| 02:09 ET | 100 | 1.985 |
| 02:15 ET | 1187 | 1.98 |
| 02:20 ET | 200 | 1.97 |
| 02:27 ET | 100 | 1.96 |
| 02:33 ET | 300 | 1.9607 |
| 02:38 ET | 1000 | 1.97 |
| 02:40 ET | 5000 | 1.9797 |
| 02:44 ET | 300 | 1.975 |
| 02:45 ET | 423 | 1.97 |
| 02:49 ET | 100 | 1.97 |
| 02:58 ET | 118 | 1.964 |
| 03:00 ET | 300 | 1.96 |
| 03:02 ET | 300 | 1.96 |
| 03:03 ET | 242 | 1.96 |
| 03:07 ET | 100 | 1.95 |
| 03:14 ET | 3016 | 1.96 |
| 03:20 ET | 100 | 1.95 |
| 03:21 ET | 100 | 1.95 |
| 03:23 ET | 615 | 1.95 |
| 03:27 ET | 100 | 1.95 |
| 03:30 ET | 300 | 1.95 |
| 03:34 ET | 200 | 1.95 |
| 03:36 ET | 456 | 1.95 |
| 03:38 ET | 200 | 1.96 |
| 03:39 ET | 100 | 1.95 |
| 03:41 ET | 2000 | 1.9686 |
| 03:45 ET | 5801 | 1.965 |
| 03:48 ET | 103 | 1.965 |
| 03:50 ET | 1100 | 1.965 |
| 03:52 ET | 4250 | 1.97 |
| 03:54 ET | 1100 | 1.96 |
| 03:56 ET | 1950 | 1.97 |
| 03:57 ET | 4772 | 1.955 |
| 03:59 ET | 54914 | 1.97 |
Sep 3, 2024
Tenaya Therapeutics to Participate in Upcoming Investment Conferences, from 8:30AM ET on Tuesday Sep 03, 2024 by Dow Jones
8:30AM ET on Tuesday Sep 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Tenaya Therapeutics Inc | 155.8M | -1.3x | --- |
Context Therapeutics Inc | 156.0M | -1.8x | --- |
Achieve Life Sciences Inc | 150.4M | -3.9x | --- |
Inovio Pharmaceuticals Inc | 152.5M | -1.2x | --- |
Immunic Inc | 144.1M | -1.0x | --- |
Invivyd Inc | 143.3M | -0.6x | --- |
Company Information
Tenaya Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. The Company is advancing a pipeline of novel therapies with diverse treatment modalities for rare genetic cardiovascular disorders and more prevalent heart conditions. The Company’s advanced product candidates include TN-201, TN-401, and TN-301. TN-201 is an adeno-associated virus serotype 9 (AAV9)-based gene therapy being developed to treat the underlying cause of MYBPC3 associated HCM by delivering a working MYBPC3 gene to specific cells of the heart via a single infusion. TN-401 is the Company’s adeno-associated virus serotype 9 (AAV9)-based gene therapy being developed for the treatment of arrhythmogenic right ventricular cardiomyopathy (ARVC) due to disease-causing variants in the PKP2 gene. TN-301 is a small molecule for heart failure with preserved ejection fraction.
Contact Information
- Headquarters
- 171 Oyster Point Blvd., Suite 500SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 415-865-2066
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- David Goeddel
- Chief Executive Officer, Director
- Faraz Ali
- Chief Medical Officer
- Whittemore Tingley
- Independent Director
- Amy Burroughs
- Independent Director
- June Lee
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $155.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 78.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.54 |
Book Value | $2.04 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
